CMS introduced the program in 2010 to reduce early readmissions after hospitalization for common medical conditions.
The researchers analyzed mortality rates among Medicare patients hospitalized for heart attacks, heart failure and pneumonia to examine the effect of the readmissions reduction program.
The study found that between 2006 and 2014, in-hospital mortality decreased from 10.4 percent to 9.7 percent for heart attacks, from 4.3 percent to 3.5 percent for heart failure and from 5.3 percent to 4 percent for pneumonia.
In the same period, 30-day post-discharge mortality decreased for heart attacks and increased for heart failure and pneumonia, but the study authors said those increases were not linked to the readmissions reduction program.
More articles on clinical leadership and infection control:
66 Indiana hospitals hit with $12M in readmission penalties from Medicare
Viewpoint: Physician’s gender affects treatment approach for female cancer
Hospital sink traps may harbor antibiotic-resistant bacteria, study finds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
